All News about Anaptysbio Inc
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
The Analyst Landscape: 7 Takes On AnaptysBio
May 10, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Unveiling 4 Analyst Insights On AnaptysBio
April 01, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2023/01/stock-predictions.png)
![](https://g.foolcdn.com/editorial/images/772787/person-in-a-lab-looking-through-a-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/fastenal_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/11/image24_0.jpeg?width=1200&height=800&fit=crop)
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/Chem-Lab_1.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Named a BioSpace 2024 Best Places to Work Winner
November 07, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Participation in November Investor Conferences
November 01, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/09/anab.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
September 18, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit
September 12, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.